- Home
- ASND vs S Comparison
ASND vs S Comparison
Compare ASND & S Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- S
- Stock Information
- Founded
- ASND 2006
- S 2013
- Country
- ASND Denmark
- S United States
- Employees
- ASND N/A
- S N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- S EDP Services
- Sector
- ASND Health Care
- S Technology
- Exchange
- ASND Nasdaq
- S Nasdaq
- Market Cap
- ASND 7.3B
- S 8.7B
- IPO Year
- ASND 2015
- S 2021
- Fundamental
- Price
- ASND $126.51
- S $26.11
- Analyst Decision
- ASND Strong Buy
- S Buy
- Analyst Count
- ASND 13
- S 26
- Target Price
- ASND $191.77
- S $28.92
- AVG Volume (30 Days)
- ASND 422.4K
- S 3.5M
- Earning Date
- ASND 11-14-2024
- S 12-03-2024
- Dividend Yield
- ASND N/A
- S N/A
- EPS Growth
- ASND N/A
- S N/A
- EPS
- ASND N/A
- S N/A
- Revenue
- ASND $365,187,374.00
- S $723,632,000.00
- Revenue This Year
- ASND $10.30
- S $33.89
- Revenue Next Year
- ASND $90.02
- S $26.13
- P/E Ratio
- ASND N/A
- S N/A
- Revenue Growth
- ASND 115.54
- S 38.04
- 52 Week Low
- ASND $90.13
- S $14.33
- 52 Week High
- ASND $161.00
- S $30.76
- Technical
- Relative Strength Index (RSI)
- ASND 46.41
- S 48.83
- Support Level
- ASND $124.11
- S $25.32
- Resistance Level
- ASND $129.86
- S $28.42
- Average True Range (ATR)
- ASND 5.50
- S 0.78
- MACD
- ASND 0.28
- S -0.06
- Stochastic Oscillator
- ASND 56.59
- S 25.45
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
About S SentinelOne Inc.
SentinelOne is a cloud-based cybersecurity company specializing in endpoint protection. SentinelOne's primary offering is its Singularity platform that offers a single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The California-based firm was founded in 2013 and went public in 2021.